Fig. 6 | Scientific Reports

Fig. 6

From: Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery

Fig. 6

Cumulative drug release profiles of TMX and flavonoids from liposomal formulations over 24 h. TMX: Tamoxifen; NRG: Naringin; DMT: Diosmetin (A) TMX and NRG from T + N liposomes (B) TMX and DMT from T + D liposomes (C) TMX, NRG, and DMT from T + N + D liposomes. Data represent mean ± SD of three independent experiments.

Back to article page